Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 35 citing Myint: RAGE control of diabetic nephropathy in a mouse model. (0.08 sec) 

Mechanisms of disease: advanced glycation end-products and their receptor in …


SF Yan, R Ramasamy, AM Schmidt - Nature clinical practice. …, 2008 - ncbi.nlm.nih.gov
Many important biochemical mechanisms are activated in the presence of high levels of
glucose, which occur in diabetes. Elevated levels of glucose accelerate the formation of advanced
glycation end-products (AGEs). Via their chief signaling receptor-the AGE-specific ...
Cited by 27 - Related articles - BL Direct - All 3 versions

[PDF] Survey of the year 2006 commercial optical biosensor literature


RL Rich, DG Myszka - Journal of Molecular Recognition, 2007 - cspr.uthscsa.edu
We identified 1219 articles published in 2006 that described work performed using commercial
optical biosensor platforms. It is interesting to witness how the biosensor market is maturing with
an increased number of instrument manufacturers offering a wider variety of platforms. ...
Cited by 23 - Related articles - View as HTML - BL Direct - All 4 versions

Receptor for advanced glycation end products (RAGE) deficiency attenuates the …


A Soro-Paavonen, A Watson, J Li, K Paavonen, A … - Diabetes, 2008 - Am Diabetes Assoc
RESULTS—Although diabetic apoE −/− mice showed increased plaque accumulation (14.9
± 1.7%), diabetic RAGE −/− /apoE −/− mice had significantly reduced atherosclerotic plaque
area (4.9 ± 0.4%) to levels not significantly different from control apoE −/− mice (4.3 ± ...
Cited by 22 - Related articles - All 9 versions

RAGE in diabetic nephropathy


H Yamamoto, T Watanabe, Y Yamamoto, H … - Current Molecular …, 2007 - ingentaconnect.com
1 Department of Biochemistry & Molecular Vascular Biology, Kanazawa University Graduate
School of Medi- cal Science, Kanazawa, 2 Department of Biochemistry, Kanazawa Medical
University, Ishikawa, Japan Abstract: As is diabetes itself, diabetic angiopathy is a multi- ...
Cited by 18 - Related articles - BL Direct - All 2 versions

The biology of RAGE and its ligands: uncovering mechanisms at the heart of …


SF Yan, GR Barile, VD'Agati, SD Yan, R Ramasamy, … - Current Diabetes …, 2007 - Springer
The interaction of glucose-modified and inflamma- tion-promoting ligands with the receptor for
advanced glycation end products (RAGE) is emerging as a central mechanism contributing to
the diverse complications of diabetes. These ligands, particularly in oligomeric form, bind ...
Cited by 17 - Related articles - BL Direct - All 2 versions

The role of the receptor for advanced glycation end-products in lung fibrosis

- physiology.org
M He, H Kubo, K Ishizawa, AE Hegab, Y … - American Journal of …, 2007 - Am Physiological Soc
The pathogenesis of pulmonary fibrosis remains unclear. The receptor for advanced glycation
end-products (RAGE) is a multi-ligand receptor known to be involved in the process of fibrotic
change in several organs, such as peritoneal fibrosis and kidney fibrosis. The aim of this ...
Cited by 17 - Related articles - BL Direct - All 3 versions

Arguing for the motion: Yes, RAGE is a receptor for advanced glycation …


R Ramasamy, SF Yan, AM Schmidt - Nahrung/Food - interscience.wiley.com
Advanced glycation endproducts (AGEs) are an heterogenous class of compounds formed by
diverse stimuli, including hyperglycemia, oxidative stress, inflammation, renal failure, and innate
aging. Recent evidence suggests that dietary sources of AGE may contribute to ...
Cited by 8 - Related articles - BL Direct - All 2 versions

Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial …


Y Yamamoto, H Yonekura, T Watanabe, S Sakurai, … - Diabetes Research and …, 2007 - Elsevier
The formation and accumulation of advanced glycation endproducts (AGE) have been implicated
in the development of diabetic vascular complications. Their biological responses are known
to be mediated by the receptor for AGE (RAGE). Recently, AGE have been proposed to ...
Cited by 8 - Related articles - All 8 versions

De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with …


M Osawa, Y Yamamoto, S Munesue, N Murakami, S … - BBA-General Subjects, 2007 - Elsevier
Interactions between advanced glycation endproducts (AGE) and the receptor for AGE
(RAGE) have been implicated in the development of diabetic vascular complications. RAGE
has two N-glycosylation sites in and near the AGE-binding domain, and G82S mutation in ...
Cited by 7 - Related articles - All 2 versions

Assaying soluble forms of receptor for advanced glycation end products

- ahajournals.org
Y Yamamoto, J Miura, S Sakurai, T Watanabe, … - … , and Vascular Biology, 2007 - Am Heart Assoc
Currently, 2 different types of sandwich enzyme-linked immunosorbent assays (ELISAs) are commercially
available and used for measurement of circulating soluble RAGE proteins: [1] esRAGE ELISA
from B-Bridge Int. esRAGE is a splice variant form of RAGE lacking transmembrane ...
Cited by 5 - Related articles - All 5 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google